STANFORD UNIVERSITY
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- Private
- Established
- 1885-11-11
- Employees
- 10K
- Market Cap
- -
- Website
- http://www.stanford.edu
Psychosocial Treatment for Improving Chances of Survival in Women With Breast Cancer
Not Applicable
Completed
- Conditions
- First Posted Date
- 2005-09-27
- Last Posted Date
- 2013-12-04
- Lead Sponsor
- Stanford University
- Target Recruit Count
- 125
- Registration Number
- NCT00226928
A Trial of Thalidomide and Capecitabine in Metastatic Renal Cell Carcinoma
Phase 2
Completed
- Conditions
- First Posted Date
- 2005-09-27
- Last Posted Date
- 2009-04-14
- Lead Sponsor
- Stanford University
- Target Recruit Count
- 30
- Registration Number
- NCT00226980
- Locations
- 🇺🇸
Stanford University School of Medicine, Stanford, California, United States
Meditation and Hypnosis for Chronic Depressed Mood
Phase 3
Completed
- Conditions
- First Posted Date
- 2005-09-27
- Last Posted Date
- 2005-09-27
- Lead Sponsor
- Stanford University
- Registration Number
- NCT00226863
Using Hypnosis to Help Children Undergoing a Difficult Medical Procedure
Phase 3
Completed
- Conditions
- First Posted Date
- 2005-09-27
- Last Posted Date
- 2005-09-27
- Lead Sponsor
- Stanford University
- Registration Number
- NCT00226850
- Locations
- 🇺🇸
Department of Psychiatry & Behavioral Sciences, Stanford University School of Medicine, Stanford, California, United States
🇺🇸Lucile Packard Children's Hospital, Stanford, California, United States
Zoledronic Acid With Intermittent Hormonal Therapy in Patients With Prostate Cancer
- First Posted Date
- 2005-09-27
- Last Posted Date
- 2020-03-18
- Lead Sponsor
- Stanford University
- Target Recruit Count
- 23
- Registration Number
- NCT00226954
- Locations
- 🇺🇸
Stanford University School of Medicine, Stanford, California, United States
Stress, Diurnal Cortisol, and Breast Cancer Survival
Completed
- Conditions
- First Posted Date
- 2005-09-27
- Last Posted Date
- 2020-01-27
- Lead Sponsor
- Stanford University
- Target Recruit Count
- 115
- Registration Number
- NCT00226967
- Locations
- 🇺🇸
Stanford University School of Medicine, Stanford, California, United States
Phase I/II Study of Intratumoral Injection of CPG 7909, a TLR9 Agonist, Combined With Local Radiation for Patients With Recurrent Mycosis Fungoides.
Phase 1
Withdrawn
- Conditions
- First Posted Date
- 2005-09-27
- Last Posted Date
- 2016-12-01
- Lead Sponsor
- Stanford University
- Registration Number
- NCT00226993
Rosiglitazone-Induced Weight Gain
Not Applicable
Terminated
- Conditions
- Interventions
- First Posted Date
- 2005-09-23
- Last Posted Date
- 2016-10-20
- Lead Sponsor
- Stanford University
- Target Recruit Count
- 45
- Registration Number
- NCT00225225
- Locations
- 🇺🇸
Stanford University School of Medicine, Stanford, California, United States
Rituximab After Autologous Stem Cell Transplant for Relapsed B-cell Non-Hodgkin's Lymphoma
Phase 2
Completed
- Conditions
- Interventions
- First Posted Date
- 2005-09-23
- Last Posted Date
- 2014-09-15
- Lead Sponsor
- Stanford University
- Target Recruit Count
- 35
- Registration Number
- NCT00225212
- Locations
- 🇺🇸
Stanford University Medical Center, Stanford, California, United States
Combination Chemotherapy +/- Radiation in High Risk Hodgkin's Disease
- First Posted Date
- 2005-09-23
- Last Posted Date
- 2014-08-27
- Lead Sponsor
- Stanford University
- Target Recruit Count
- 45
- Registration Number
- NCT00225173
- Locations
- 🇺🇸
Stanford University Medical Center, Stanford, California, United States
© Copyright 2024. All Rights Reserved by MedPath